SCHEMBL4901009

SCHEMBL4901009

CCN(Oc1ccc(C(F)(F)F)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.37
PTGDR2 Q9Y5Y4 8/20 0.37
PPARD Q03181 3/20 0.37
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
KDM1A O60341 1/20 0.35
LMNA P02545 1/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
BMP1 P13497 1/20 0.35
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
KDM4E B2RXH2 1/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4908598 0.90 MMP9 (0.38) LMNARXRARXRBKDM4EALDH1A1
SCHEMBL4903874 0.90 ALDH1A1 (0.39) HDAC8PPARDLMNABMP1KDM4E
SCHEMBL4904268 0.89 HCRTR2 (0.41) LMNAKDM4EALDH1A1
SCHEMBL4906301 0.82 HDAC8 (0.51) HDAC8PSEN1PSEN2APH1BNCSTN
SCHEMBL4902749 0.80 PPARD (0.37) PTGDR2PPARD
SCHEMBL4901791 0.80 ALDH1A1 (0.42) LMNAMRGPRX4KDM4EALDH1A1HSD17B10
SCHEMBL4904415 0.80 ALDH1A1 (0.40) HDAC8LMNAKDM4EALDH1A1CYP2C19
SCHEMBL4897635 0.79 HDAC8 (0.53) HDAC8PPARDPSEN1PSEN2APH1B
SCHEMBL4894384 0.79 HDAC8 (0.37) HDAC8PTGDR2PPARDKDM1ALMNA
SCHEMBL4897727 0.79 MMP2 (0.48) HDAC8PPARDPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD HDAC8 882/4885PTGDR2 1175/4885PPARD 3/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HDAC8 882/4885PTGDR2 1175/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.